Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00957268 · ClinicalTrials.gov registry record · Phase 1

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

A Phase 1 study of Diabetes Mellitus, Type 2, sponsored by Takeda.

Completed
Registry status
Phase 1
Development phase
46
Enrollment target
7
Study locations

NCT00957268 is a Phase 1 study of Diabetes Mellitus, Type 2 that has completed, run by Takeda. The registered enrollment target is 46 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00957268, a Phase 1 study of Diabetes Mellitus, Type 2, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 1
Development phase
46 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to determine the pharmacokinetic and safety profile of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.

Conditions Studied

Diabetes Mellitus, Type 2

Interventions

  • DRUG Alogliptin

Study Locations (7)

Florida

  • - Miami
  • - Pineallas Park

Kentucky

  • - Louisville

North Carolina

  • - Durham

Pennsylvania

  • - Philadelphia

Tennessee

  • - Memphis

Texas

  • - San Antonio

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2009-09
Est. Completion 2013-11
Phase Phase 1

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00957268

The ClinicalTrials.gov registry entry for NCT00957268 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Alogliptin is the first listed.

NCT00957268 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, Kentucky, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00957268 about?

NCT00957268 is a clinical study titled "Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus". The purpose of this study is to determine the pharmacokinetic and safety profile of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.

What is the current status of trial NCT00957268?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2009-09. Estimated completion is 2013-11.

What conditions does trial NCT00957268 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00957268?

The interventions under investigation include: Alogliptin (DRUG).

Who is sponsoring clinical trial NCT00957268?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00957268 being conducted?

This trial has 7 study locations across Florida, Kentucky, North Carolina, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.